Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
-
Sonoma Pharmaceuticals (SNOA) PT Lowered to $7 at Maxim Group
-
Sonoma Pharmaceuticals (SNOA) PT Raised to $11 at Maxim Group
-
Sonoma Pharmaceuticals (SNOA) PT Raised to $10 at Maxim Group Following 4Q
-
Sonoma Pharmaceuticals (SNOA) PT Raised to $9 at Maxim Group on Break Even Push

